Future Patient - Telerehabilitation of Patients With Atrial Fibrillation
NCT ID: NCT06101485
Last Updated: 2023-10-26
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
208 participants
INTERVENTIONAL
2023-01-01
2025-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Future Patient - Telerehabilitation of Atrial Fibrillation Patients
NCT04493437
Atrial Fibrillation, Prevention and Rehabilitation
NCT06337045
Rehabilitation of Patients With Atrial Fibrillation
NCT03035539
Reaching the Frail Elderly for the Management of Atrial Fibrillation
NCT04162548
A Precision Medicine Approach to the Prevention of Depression in Patients With Atrial Fibrillation
NCT07178691
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Telerehabilitation group
The telerehabilitation group (n=104) will participate in the FP-AF program for 16 weeks. The program is administered by the AF clinics and the healthcare centers (HC) in Viborg, Skive and Silkeborg Municipalities. After enrollment, the patients will have an individual meeting with the project nurse. Here the patient (and relatives, if necessary) will be instructed in the use of the technologies and an individual plan will be formulated for the AF patient's telerehabilitation. After participation in 16 weeks the patients start a 12 weeks follow-up period, where they will only measure steps and have access to the Heartportal on their own devices.
Telerehabilitation
Telerehabilitation platform: Hjerteportalen, blood pressure monitor (iHealth(neo/BP5s), weight scale (iHealth Lina), Activity tracker (FitBit inspire 3), ECG monitor (AliveCor KardiaMobile), sleep sensor (Emfit QS), video consultation (VDX by MedCom)
Conventional rehabilitation
The control group (n=104) will follow the conventional care regime in the AF clinic and will not have contact to the project nurse. When the AF patients are in a stable condition, they will be followed by their general practitioner (GP). The control group will be in the study for 28 weeks.
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Telerehabilitation
Telerehabilitation platform: Hjerteportalen, blood pressure monitor (iHealth(neo/BP5s), weight scale (iHealth Lina), Activity tracker (FitBit inspire 3), ECG monitor (AliveCor KardiaMobile), sleep sensor (Emfit QS), video consultation (VDX by MedCom)
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Adults over 18 years
* Living in Skive, Viborg or Silkeborg Municipalities
* Living at home and capable of caring for themselves
* Have basic computer skills or having a relative/friend with basic computer skills
Exclusion Criteria
* Refusal or inability to cooperate; or patient not does not speak, read or understand Danish
* Life expectancy less than a year
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Department of Cardiology, Viborg Regional Hospital
UNKNOWN
Department of Cardiology, Silkeborg Regional Hospital
UNKNOWN
Center for Innovative Medical Technologies (CIMT), Odense University Hospital
UNKNOWN
Laboratory for Welfare Technology, Department of Health Science and Technology, Aalborg University
UNKNOWN
Aalborg University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Birthe Dinesen
Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Birthe Dinesen, MSc, Ph.D
Role: PRINCIPAL_INVESTIGATOR
Aalborg University
Dorthe Svenstrup, MD, Ph.D
Role: STUDY_DIRECTOR
Central Jutland Regional Hospital, Viborg
Lars Frost, MD, Ph.D, DMSc
Role: STUDY_DIRECTOR
Central Jutland Regional Hospital, Silkeborg
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Central Jutland Regional Hospital
Viborg and Silkeborg, , Denmark
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
References
Explore related publications, articles, or registry entries linked to this study.
Dinesen B, Albertsen AE, Joensen EDR, Spindler H, Jensen KM, Kidholm K, Frost L, Dittman L, Gunasegaram M, Johnsen SP, Jochumsen MR, Svenstrup D. Future Patient-Telerehabilitation of Patients With Atrial Fibrillation: Protocol for a Multicenter, Mixed Methods, Randomized Controlled Trial. JMIR Res Protoc. 2025 Feb 18;14:e64259. doi: 10.2196/64259.
Related Links
Access external resources that provide additional context or updates about the study.
Read more about the trial at the homepage for the Laboratory for Welfare Technology - Digital health \& rehabilitation, Aalborg University
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
N-20220056
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.